Showing results (1001-1010 of 1,029) with videos related to
Sort By:
Pageof 103
Breast (Edinburgh, Scotland)|May 27, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitorsRoberta Scafetta, Marco Donato, Carla Gullotta, et al.The New England Journal of Medicine|October 23, 2009
Multicenter analysis of glucocerebrosidase mutations in Parkinson's diseaseE Sidransky, M A Nalls, J O Aasly, et al.The Oncologist|April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone MetastasesRoberta Scafetta, Marco Donato, Carla Gullotta, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian studyRoberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.JAMA Neurology|June 18, 2019
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysisClaire Bridel, Wessel N van Wieringen, Henrik Zetterberg, et al.Physical Review Letters|August 11, 2023
Frequency-Dependent Squeezed Vacuum Source for the Advanced Virgo Gravitational-Wave DetectorF Acernese, M Agathos, A Ain, et al.Physical Review Letters|August 26, 2022
Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing RunR Abbott, T D Abbott, F Acernese, et al.Physical Review Letters|July 2, 2021
Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing RunR Abbott, T D Abbott, S Abraham, et al.Physical Review Letters|September 15, 2025
Observation of the Charged-Particle Multiplicity Dependence of σ_{ψ(2S)}/σ_{J/ψ} in p-Pb Collisions at 8.16 TeVV Chekhovsky, A Hayrapetyan, V Makarenko, et al.Physical Review Letters|September 15, 2025
Measurement of WWZ and ZH Production Cross Sections at sqrt[s]=13 and 13.6 TeVA Hayrapetyan, V Makarenko, A Tumasyan, et al.Pageof 103